Preliminary Investigation of a Smart Compression Therapy Prototype

NCT ID: NCT05610241

Last Updated: 2023-09-07

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

11 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-03-04

Study Completion Date

2023-03-21

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Compression wraps treat venous leg ulcers when applied correctly. Often, clinicians apply the wraps at the wrong compression, or the wrap loosens, stopping clinical benefits. The study aims to show the feasibility of a smart compression prototype to maintain a set compression level in healthy volunteers. Each volunteer will wear the prototype device on one leg and a standard compression wrap on the other. Volunteers will pump their calves, walk, lie down, and stand at zero, one, and four hours. A pressure sensor placed over each calf will record the compression level during the activities. Volunteers will provide subjective feedback on each device concerning comfort and usability. After four hours, researchers will remove the standard wrap. Volunteers will use the prototype device during daily activities for three days. During the three days, the volunteers will complete a daily journal. The journal will capture the user experience and time the volunteer used the device. A final site visit allows researchers to conduct exit interviews and download the history of applied compression. Researchers will use the data to show that the prototype device maintains therapeutic compression and prove the usability of the device.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Venous Leg Ulcer Venous Insufficiency of Leg

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Healthy volunteer study where participants serve as their own control, the control condition will be assigned to one leg and the experimental condition applied to the other leg.
Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Caregivers
The clinical research nurse applying the compression interventions will be blinded from interface pressure measurements

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Compression Therapy System Prototype

Identifies legs randomized to receive the experimental intervention

Group Type EXPERIMENTAL

Compression Therapy System Prototype

Intervention Type DEVICE

A device designed to deliver compression therapy at a pre-set level to the lower leg for legs with a circumference between 30-50 cm. The device provides compression through a series of three air bladders and is controlled by a battery-powered electronic module that controls compression levels by monitoring bladder pressure.

Coban 2 (2 Layer Compression Wrap)

Identifies the legs randomized to receive the control intervention

Group Type ACTIVE_COMPARATOR

Standard Compression

Intervention Type DEVICE

Coban 2 represents the standard of care 2-layer compression wrap used to treat venous leg ulcers. The device consists of a comfort layer and a compression layer. A clinician applies the device to establish compression therapy.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Compression Therapy System Prototype

A device designed to deliver compression therapy at a pre-set level to the lower leg for legs with a circumference between 30-50 cm. The device provides compression through a series of three air bladders and is controlled by a battery-powered electronic module that controls compression levels by monitoring bladder pressure.

Intervention Type DEVICE

Standard Compression

Coban 2 represents the standard of care 2-layer compression wrap used to treat venous leg ulcers. The device consists of a comfort layer and a compression layer. A clinician applies the device to establish compression therapy.

Intervention Type DEVICE

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

2 Layer Compression Wrap 2 Layer Compression Bandage Coban 2

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Intact, healthy skin at the application site in both legs
* Calf circumferences to be within 30 - 50 cm between the medial and lateral head of the gastrocnemius
* Able to understand the Patient Information Leaflet
* Willing and able to give informed consent
* Able to wear, don and doff the compression device without external help
* Willing and able to follow the requirements of the clinical investigation plan
* Presence of pedal pulses identified by hand-held Doppler (8 MHz)
* Ankle Brachial Pressure Index between 0.9 and 1.4

Exclusion Criteria

* History of signs of previous deep or superficial vein thrombosis/pulmonary embolism
* Peripheral artery disease ( or ABPI \< 0.90 or \> 1.4), critical limb ischemia, or arterial ulceration
* Varicose veins, varicose eczema, or venous ulceration
* Chronic lower limb swelling, edema, lymphedema, or lipoedema
* Recent surgery within the last three months (such as abdominal, gynecological, hip or knee replacement, or lower limb) that may affect the study in the opinion of the investigator
* Recent trauma to a lower limb within the last three months
* Chronic obesity (defined as BMI index \>40 kg/m\^2)
* Diabetes mellitus
* Pregnancy
* A pulse rate of fewer than 40 beats/minute
* A sitting systolic blood pressure of \> 180 and \< 100 mmHg and/or a sitting diastolic pressure of \> 100 mmHg
* Any significant illness during the previous four (4) weeks
* Participation in any clinical study during the eight (8) weeks preceding the screening period
* Any evidence of edema or pain
* Skin diseases, including wounds on the feet or lower limbs
* Any history of heart, liver, kidney, or vascular diseases
* History of having been prescribed compression stockings for treatment of a medical condition
* Serious allergies
* Dermatitis with oozing or fragile skin
* Persons currently using NSAID, Diuretics, Vasodilators, and steriods
* Drivers and Driving Professionals
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Royal College of Surgeons, Ireland

OTHER

Sponsor Role collaborator

Tyndall National Institute

UNKNOWN

Sponsor Role collaborator

Enterprise Ireland

OTHER_GOV

Sponsor Role collaborator

DeRoyal Industries, Inc.

INDUSTRY

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Declan Patton, PhD

Role: STUDY_DIRECTOR

RCSI University of Medicine and Health Sciences

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

RCSI Education and Research Centre

Dublin, , Ireland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Ireland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CI52248

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Compression and CO2 Laser for Leg Wounds
NCT04198454 ENROLLING_BY_INVITATION NA
AI Driven Biofeedback Wearable
NCT04921410 COMPLETED NA
Compression Device Safety Study on Edema
NCT00732719 COMPLETED PHASE2